Sinotherapeutics Inc. to Raise RMB600m via STAR Board IPO for Generic Drug Expansion
Sinotherapeutics Inc., a Shanghai-based generic drug developer, is set to make an initial public offering...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity